Australia's Therapeutic Goods Administration (TGA) has today given Keytruda® (pembrolizumab) provisional approval for patients with unresectable or metastatic, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) bowel cancer.
In the first week of Bowel Cancer Awareness Month 2019, the University of Sydney officially opened the Kolling Institute node of their Sydney Mass Spectrometry core facility.
The facility was made possible with a significant financial gift of $500,000 from Bowel Cancer Australia, established to support the research of the Lawrence Penn Chair of Bowel Cancer Research, Professor Mark Molloy PhD and his research team.
Members of the Bowel Cancer Australia board and guests were in attendance, along with the Deputy Vice-Chancellor (Research), Professor Duncan Ivison and Core Facilities Director, Professor Simon Ringer presiding.
Of the 4.1 million people invited to participate in the National Bowel Cancer Screening Program between January 2016 and December 2017, only four in every ten took up the offer according to the latest AIHW report.
The rate was the same as for the previous rolling 2-year period (2015–2016) (41%) and is now hovering at the same rate it was in 2009, before dropping to just 36.1% in 2012.
As an in-house Bowel Care Nurse at Bowel Cancer Australia, Fiona has dedicated the past eight years to the prevention, early diagnosis, research, quality treatment and the best care for everyone affected by bowel cancer.
Described as a lifeline, Bowel Cancer Australia’s team of Bowel Care Nurses and Nutritionist adds an extra layer of support to the trusted relationship patients have with their treating medical team at a very difficult time.
In recognition of the important role our team of Bowel Care Nurses provide, the Cancer Nurses Society of Australia (CNSA) has chosen to feature Fiona as their Member of the Moment this June.
It’s Never Too Young Awareness Week (3-9 June 2019), and Bowel Cancer Australia is raising much needed awareness that you’re never too young to have bowel cancer.
A new global study of seven high-income countries has found that in the decade up to 2014, Australia’s second most deadly cancer is on the rise in people under 50.